10x Genomics, Inc. — Director's Dealing 2021

Aug 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-08-02

Reporting Person: Hindson Benjamin J. (Director, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-02	Class A Common Stock	M	11114	$1.20	Acquired	58568	Direct
2021-08-02	Class A Common Stock	M	30552	$5.04	Acquired	89120	Direct
2021-08-02	Class A Common Stock	S	5903	$178.2469	Disposed	83217	Direct
2021-08-02	Class A Common Stock	S	8050	$179.0802	Disposed	75167	Direct
2021-08-02	Class A Common Stock	S	10713	$180.1341	Disposed	64454	Direct
2021-08-02	Class A Common Stock	S	8800	$181.1319	Disposed	55654	Direct
2021-08-02	Class A Common Stock	S	5200	$181.9808	Disposed	50454	Direct
2021-08-02	Class A Common Stock	S	1800	$183.0226	Disposed	48654	Direct
2021-08-02	Class A Common Stock	S	800	$184.0244	Disposed	47854	Direct
2021-08-02	Class A Common Stock	S	400	$184.9525	Disposed	47454	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-02	Stock Option (right to buy)	$1.20	M	11114	Disposed	2027-10-18	Class A Common Stock (11114)	Direct
2021-08-02	Stock Option (right to buy)	$5.04	M	30552	Disposed	2028-11-02	Class A Common Stock (30552)	Direct

Footnotes

F1: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $177.63 to $178.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: This transaction was executed in multiple trades at prices ranging from $178.63 to $179.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: This transaction was executed in multiple trades at prices ranging from $179.63 to $180.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F5: This transaction was executed in multiple trades at prices ranging from $180.63 to $181.625. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6: This transaction was executed in multiple trades at prices ranging from $181.63 to $182.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F7: This transaction was executed in multiple trades at prices ranging from $182.63 to $183.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8: This transaction was executed in multiple trades at prices ranging from $183.66 to $184.595. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F9: This transaction was executed in multiple trades at prices ranging from $184.84 to $184.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F10: This option, originally for 200,000 shares, of which 140,032 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2017 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F11: This option, originally for 175,000 shares, of which 30,552 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.